In this episode, Paul Romness, CEO of OSTherapies, discusses his journey in the biotech industry, the challenges and breakthroughs in developing treatments for osteosarcoma, and the innovative approaches his company is taking to enhance cancer therapies. He emphasizes the importance of collaboration, the potential market for their treatments, and the unique relationship between canine and human osteosarcoma. The conversation also touches on the financial aspects of running a biotech company and the regulatory landscape they navigate as a public company.

OS Therapies Website https://ostherapies.com/

Nano Cap Podcast Website https://www.nanocappod.com/